BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19810962)

  • 1. Alzheimer's disease: from molecular pathogenesis to innovative therapies.
    Scarpini E; Cogiamanian F
    Expert Rev Neurother; 2003 Sep; 3(5):619-30. PubMed ID: 19810962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current and future medical treatment of Alzheimer's disease].
    Lemper JC
    Rev Med Brux; 2005 Sep; 26(4):S294-9. PubMed ID: 16240877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: from pathology to therapeutic approaches.
    Jakob-Roetne R; Jacobsen H
    Angew Chem Int Ed Engl; 2009; 48(17):3030-59. PubMed ID: 19330877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options in Alzheimer's disease.
    Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
    Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in the development of disease-modifying therapies for Alzheimer's disease].
    Abe K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):1-8. PubMed ID: 20297736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
    Cummings JL; Mendez MF
    Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Perspectives of therapy of Alzheimer's disease].
    Sienkiewicz-Jarosz H; Kostowski W
    Psychiatr Pol; 2000; 34(4):623-40. PubMed ID: 11059261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current approaches in the treatment of Alzheimer's disease.
    Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ
    Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets.
    Caraci F; Copani A; Nicoletti F; Drago F
    Eur J Pharmacol; 2010 Jan; 626(1):64-71. PubMed ID: 19837057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards testing the amyloid hypothesis: inhibitors of APP processing.
    Olson RE; Copeland RA; Seiffert D
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):390-401. PubMed ID: 11727304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis.
    Marcello E; Epis R; Di Luca M
    Eur J Pharmacol; 2008 May; 585(1):109-18. PubMed ID: 18377893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
    Masters CL; Cappai R; Barnham KJ; Villemagne VL
    J Neurochem; 2006 Jun; 97(6):1700-25. PubMed ID: 16805778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
    Yan R; Bienkowski MJ; Shuck ME; Miao H; Tory MC; Pauley AM; Brashier JR; Stratman NC; Mathews WR; Buhl AE; Carter DB; Tomasselli AG; Parodi LA; Heinrikson RL; Gurney ME
    Nature; 1999 Dec; 402(6761):533-7. PubMed ID: 10591213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential for BACE1 inhibitors in the treatment of Alzheimer's disease.
    Hussain I
    IDrugs; 2004 Jul; 7(7):653-8. PubMed ID: 15243867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers.
    Silverberg GD; Mayo M; Saul T; Carvalho J; McGuire D
    Expert Rev Neurother; 2004 Jan; 4(1):97-107. PubMed ID: 15853620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of gamma-secretase activity in Alzheimer's disease.
    Zhou S; Zhou H; Walian PJ; Jap BK
    Biochemistry; 2007 Mar; 46(10):2553-63. PubMed ID: 17298085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.